Indrayani Biotech Ltd
Incorporated in 1992, Indrayani Biotech
Ltd is in the business of Foods & Hospitality, Engineering and Healthcare[1]
- Market Cap ₹ 194 Cr.
- Current Price ₹ 53.6
- High / Low ₹ 99.7 / 46.8
- Stock P/E 26.8
- Book Value ₹ 15.9
- Dividend Yield 0.00 %
- ROCE 23.0 %
- ROE 36.2 %
- Face Value ₹ 10.0
Pros
- Company is expected to give good quarter
Cons
- Stock is trading at 3.38 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding is low: 33.6%
- Tax rate seems low
- Company has a low return on equity of 12.0% over last 3 years.
- Promoter holding has decreased over last 3 years: -16.8%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Hotels & Restaurants Industry: Hotels
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2010 | Mar 2011 | Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|
0 | 39 | 58 | 50 | 21 | 61 | 163 | 171 | |
0 | 39 | 57 | 47 | 26 | 54 | 145 | 155 | |
Operating Profit | -0 | 1 | 1 | 3 | -5 | 7 | 17 | 16 |
OPM % | -105% | 2% | 1% | 6% | -24% | 11% | 11% | 10% |
0 | 0 | 0 | 0 | -4 | 0 | 4 | 2 | |
Interest | 0 | 0 | 0 | 1 | 2 | 2 | 6 | 7 |
Depreciation | 0 | 0 | 0 | 1 | 0 | 1 | 3 | 4 |
Profit before tax | -0 | 0 | 0 | 1 | -11 | 4 | 12 | 8 |
Tax % | 0% | 150% | 300% | 0% | 0% | 0% | 3% | |
-0 | -0 | -0 | 1 | -11 | 4 | 12 | 8 | |
EPS in Rs | -0.14 | -0.16 | 2.22 | -3.28 | 1.30 | 3.49 | 2.11 | |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 48% |
TTM: | 31% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 148% |
TTM: | -34% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 58% |
3 Years: | 105% |
1 Year: | -28% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 12% |
Last Year: | 36% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2010 | Mar 2011 | Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|
Equity Capital | 6 | 4 | 4 | 4 | 34 | 34 | 34 | 43 |
Reserves | -6 | -0 | -0 | 27 | -15 | -10 | 10 | 14 |
Preference Capital | 0 | 0 | 0 | 0 | 0 | 0 | 9 | |
0 | 0 | 0 | 14 | 16 | 19 | 70 | 88 | |
1 | 6 | 9 | 7 | 5 | 8 | 41 | 33 | |
Total Liabilities | 1 | 10 | 12 | 51 | 40 | 51 | 156 | 179 |
1 | 6 | 6 | 17 | 15 | 17 | 57 | 57 | |
CWIP | -0 | 0 | 0 | 14 | 14 | 13 | 14 | 14 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 |
0 | 4 | 7 | 21 | 11 | 22 | 85 | 100 | |
Total Assets | 1 | 10 | 12 | 51 | 40 | 51 | 156 | 179 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2010 | Mar 2011 | Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|
1 | 2 | 6 | 0 | 4 | 16 | ||
-3 | -0 | -4 | -1 | -1 | -47 | ||
2 | -1 | -1 | -0 | -3 | 33 | ||
Net Cash Flow | 0 | 1 | 1 | -1 | 1 | 2 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2010 | Mar 2011 | Mar 2012 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|
Debtor Days | 0 | 26 | 26 | 52 | 84 | 84 | 67 |
Inventory Days | 365 | 57 | 25 | 14 | 44 | ||
Days Payable | 365 | 70 | 77 | 52 | 81 | ||
Cash Conversion Cycle | 0 | 26 | 26 | 38 | 32 | 46 | 30 |
Working Capital Days | -1,883 | -1 | -8 | 80 | 71 | 56 | 83 |
ROCE % | 28% | 12% | -13% | 16% | 23% |
Documents
Announcements
- Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015 26 Apr
- Compliance Certificate Under Regulation 7(3) Of SEBI (LODR) Regulations, 2015 For The Year Ended March 31, 2024 12 Apr
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
6 Apr - DP) Regulations 2018, for the quarter ended March 31, 2024.
- Closure of Trading Window 1 Apr
- Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate 29 Mar
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
-
Financial Year 2008
from bse
Business Overview:[1]
IBL has multiple business units managed by an
independent team of field experts. It operates
in Food and Hospitality, Dairy, Healthcare & Pharma, Engineering, Biotech, Agriculture and Infrastructure